Forum Discussion
Groundbreaking genomic test could spare millions of breast cancer patients chemotherapy
I wonder if there were any members ON the Optima Trial?
The Optima trial, led by University College London, followed more than 4,000 patients with newly diagnosed breast cancer in the UK, Norway, Sweden, Australia, New Zealand and Thailand. It found that those with a low score on the ge
Karen Bonham was part of successful trial for genomic test that determines which women with breast cancer can safely avoid chemotherapy
https://www.theguardian.com/society/2026/may/29/breast-cancer-chemotherapy-genomic-test-case-study
2 Replies
Thank you for sharing this arpie and bringing light to this important topic - it is always exciting and hopeful to see what potential treatments can be made available with research. Our Policy & Advocacy director Vicki Durston has been following this closely - check her latest post here
